Morpholine → (4-Isopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone

To a solution of 4-(4-isopropyl-piperazine-1-carbonyl)-benzaldehyde (32.0 g, 123 mmol) in THF (650 mL) was added morpholine (21.4 g, 246 mmol), in a slow stream via an addition funnel over 15 min, and the resulting mixture was stirred at room temperature for 40 min. The reaction mixture was treated with NaBH(OAc)3 (38.4 g, 172 mmol) in portions over 40 min, was stirred at room temperature for 16 h, and then concentrated to a residue. The residue was diluted with EtOAc (400 mL), cooled to 0° C., and treated with 1 N NaOH (250 mL). The biphasic solution stirred at 0° C. for 30 min. The phases were separated and the aqueous layer was extracted with EtOAc (2×200 mL) and CH2Cl2 (2×100 mL). The organic layers were combined, washed with brine (1×300 mL), dried (Na2SO4), and concentrated to yield the title compound as a pale yellow oil.

1. stirringwas stirred at room temperature for 16 h
2. concentrationconcentrated to a residue
3. additionThe residue was diluted with EtOAc (400 mL)
4. temperaturecooled to 0° C.
5. additiontreated with 1 N NaOH (250 mL)
6. stirringThe biphasic solution stirred at 0° C. for 30 min
7. customThe phases were separated
8. extractionthe aqueous layer was extracted with EtOAc (2×200 mL) and CH2Cl2 (2×100 mL)
9. washwashed with brine (1×300 mL)
10. dry with materialdried (Na2SO4)
11. concentrationconcentrated

ORD record

ord-ac430df7130a4a78b6a9357ddb3925db

Source dataset

uspto-grants-2010_06

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US07728129B2